David Solow-Cordero

Title: David Solow-Cordero: Innovator in Edg-3 Receptor Modulation

Introduction

David Solow-Cordero is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the modulation of Edg-3 receptors. His innovative work has the potential to impact therapeutic approaches for various conditions.

Latest Patents

David holds a patent for "Methods of treating conditions associated with an Edg-3 receptor." This patent outlines methods for modulating Edg-3 receptor-mediated biological activity in cells. The invention describes how a cell expressing the Edg-3 receptor can be contacted with a modulator to influence its biological activity. Additionally, it provides a method for administering a therapeutically effective amount of a modulator to a subject. The patent also presents compounds and compositions useful for the modulation of the Edg-3 receptor.

Career Highlights

David is currently associated with Maniv Energy Capital, where he applies his expertise in receptor modulation. His work is pivotal in advancing the understanding of Edg-3 receptors and their biological implications.

Collaborations

David collaborates with talented individuals such as Geetha Shankar and Juliet V Spencer, contributing to a dynamic research environment.

Conclusion

David Solow-Cordero's innovative work in the modulation of Edg-3 receptors showcases his commitment to advancing biotechnology. His contributions have the potential to lead to significant therapeutic advancements in the treatment of various conditions.